Friday, August 14, 2026

Acceptilol™ is coming to the conference floor

JO-EL Therapeutics
A smiling JO-EL Therapeutics scientist sitting on a giant Acceptilol tablet in front of the conference booth

JO-EL Therapeutics is heading to the conference floor, and this year we are bringing more than groundbreaking science, questionable confidence, and the Continuous Compliance Platform.

We are bringing Acceptilol™.

Visit the JO-EL Therapeutics booth throughout the conference to meet our team, explore our technology, collect limited-edition JO-EL swag, and participate in what our Legal department has repeatedly asked us not to describe as a clinical study:

The Acceptilol™ Speed Eating Competition

The rules are simple.

Contestants will race to consume a competition-sized quantity of Acceptilol™ tablets as quickly as possible. Presicription is not required, we will provide the paperwork in place.

Fastest time wins.

Scientific technique is optional. Determination is mandatory.

And unlike most pharmaceutical competitions, there is actually a meaningful endpoint.

The Grand Prize

The fastest contestant will receive:

A ONE-YEAR SUPPLY OF ACCEPTILOL™ BUTT CAPSULES*

That’s right. A full year. Rectal administration.

Because when JO-EL Therapeutics identifies a promising route of administration, we commit to it.

*Novelty product. Please do not put conference swag in your rectum. JO-EL’s fictional regulatory department cannot believe this disclaimer was necessary.

Come for the Science. Leave With Things.

Visitors to the JO-EL booth will also have the opportunity to pick up exclusive conference swag, including Acceptilol™ prescription bottles filled with confidence, Certified Human-in-the-Loop badges, JO-EL laboratory notebooks, Continuous Compliance survival kits, and limited-edition Acceptilol™ merchandise.

Quantities are limited because our supply chain team apparently believes scarcity creates brand value.

They may be right.

Continuous Compliance. Continuous Innovation. Questionable Delivery Routes.

Between competitions, our team will demonstrate the JO-EL Continuous Compliance Platform, including continuous evidence generation, AI oversight, intelligent audit preparation, and our latest work using regulatory and auditor questions to dynamically generate compliance documentation.

We believe pharmaceutical development can move faster without sacrificing oversight.

We also believe conference booths have become unbearably boring.

So come meet the team. See the platform. Take some swag. Eat some Acceptilol™. And perhaps leave the rectal formulation to the winner.

JO-EL Therapeutics — Popping drugs to market with confidence.